Predicting Nociplastic Pain in Carpal Tunnel Syndrome Through Quantitative Sensory Testing
Quantitative Sensory Testing to Predict Progression to Nociplastic Pain in Carpal Tunnel Syndrome: A Prospective Cohort Study
1 other identifier
observational
120
1 country
1
Brief Summary
This study aims to investigate the predictive value of quantitative sensory testing (QST) in identifying patients with carpal tunnel syndrome (CTS) who are at risk of developing nociplastic pain.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Jul 2023
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
July 18, 2023
CompletedStudy Start
First participant enrolled
July 21, 2023
CompletedFirst Posted
Study publicly available on registry
July 25, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
July 21, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
November 30, 2024
CompletedJuly 25, 2023
July 1, 2023
1 year
July 18, 2023
July 18, 2023
Conditions
Outcome Measures
Primary Outcomes (1)
Progression to Nociplastic Pain
Development of nociplastic pain in patients with carpal tunnel syndrome, as identified by a Kosek, by clinical criteria suggest by E., Clauw, D., Nijs, J., Baron, R., Gilron, I., Harris, R. E., ... \& Sterling, M. (2021). Chronic nociplastic pain affecting the musculoskeletal system: clinical criteria and grading system. Pain, 162(11), 2629-2634.
1 year from the start of the study
Secondary Outcomes (1)
Change in Quantitative Sensory Testing (QST) Measures
Changes in QST at baseline and 1 year
Other Outcomes (1)
Change in Hand Function
Change in hand function measures at baseline and 1 year.
Study Arms (1)
Carpal Tunnel Syndrome (CTS) Patients
Adults with clinical and electrodiagnostic evidence of carpal tunnel syndrome.
Interventions
Quantitative Sensory Testing (QST) is a non-invasive diagnostic method used to assess sensory dysfunction. The test evaluates individual thresholds and pain responses to different types of mechanical, thermal, and electrical stimuli. For this study, QST will be used to gather baseline sensory data for patients with carpal tunnel syndrome. This information will then be used to predict the progression to nociplastic pain over a one-year follow-up period.
Eligibility Criteria
Adults with clinical and electrodiagnostic evidence of carpal tunnel syndrome.
You may qualify if:
- Adults ages 18-60
- Clinical diagnosis of CTS based on presence of parasthesias and/or pain in median nerve distribution, positive Phalen's test and/or Tinel's sign, and nocturnal symptoms
- Electrodiagnostic evidence of median neuropathy at the wrist:
- Prolonged median motor distal latency \>4.2 ms
- Prolonged median sensory latency \>3.4 ms
- Symptom duration between 6 months and 2 years (to exclude very early or very late stages)
- Pain severity of ≥5 on 0-10 numerical rating scale
- No evidence of thenar muscle atrophy on physical exam
- No prior surgery or fracture of the affected wrist
- No evidence of comorbid diabetes mellitus, cervical radiculopathy, polyneuropathy, or other neuromuscular disorders
You may not qualify if:
- Diabetes mellitus, as a common cause of polyneuropathy, which can confound QST measures.
- Cervical radiculopathy or other upper limb neuropathies, which can cause overlapping sensory symptoms and signs.
- History of wrist fracture or surgery, which may cause structural abnormalities affecting nerve function.
- Pregnancy, due to physiological changes that can affect nerve function.
- Patients with severe thenar muscle atrophy, indicating long-standing severe median neuropathy.
- Patients unable to provide informed consent or comply with study procedures.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Outpatient clinic of faculty of physical therapy, Ahram Canadian University
Al Ḩayy Ath Thāmin, Giza Governorate, 3221405, Egypt
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- STUDY CHAIR
Amal Fawzy, Ph.d
Faculty of Physical Therapy, Ahram Canadian University
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Lecturer of Physical Therapy and Director of Electromyography Lab
Study Record Dates
First Submitted
July 18, 2023
First Posted
July 25, 2023
Study Start
July 21, 2023
Primary Completion
July 21, 2024
Study Completion
November 30, 2024
Last Updated
July 25, 2023
Record last verified: 2023-07
Data Sharing
- IPD Sharing
- Will not share